Western blotting revealed that silencing PTEN significantly activated the AKT/mTOR pathway, suppressed CD24‐induced conversion of LC3‐I to LC3‐II, and simultaneously increased p62 protein expression in RB cells treated with VCR (Fig. 6C,D and Fig. S3B). This evidence concerns the gene MTOR and retinoblastoma.